Erythematotelangiectatic rosacea : The combination of 0.5% brimonidine tartrate gel and broadband pulse light therapy to reverse its effects
© 2020 Wiley Periodicals LLC..
Rosacea is a common skin disease that is troublesome for both the patients and the dermatologists. Erythema, telangiectasia, papulopustular changes, and phymatous changes are the main problems faced by the patients and dermatologists in everyday practice. Due to the chronic and relapsing nature of the disease, patients are usually unsatisfied with conventional treatment methods. We report a case of a patient with rosacea, erythematotelangiectatic subtype with an eight-year history of progressive worsening and experience of combined therapy based on the broadband pulse light and topical 0.5% brimonidine tartrate gel. The effectiveness of the therapy was evaluated using multispectral skin imaging that enables to define morphological patterns of the pathological skin areas in a real-time mode as well as to create the map of hemoglobin distribution and to measure its concentration in the rosacea foci. In this case report, an efficacy and very good tolerability of the abovementioned treatment have been demonstrated.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Journal of cosmetic dermatology - 20(2021), 7 vom: 10. Juli, Seite 2116-2118 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rusina, Tatiana [VerfasserIn] |
---|
Links: |
---|
Themen: |
4S9CL2DY2H |
---|
Anmerkungen: |
Date Completed 22.06.2021 Date Revised 22.06.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/jocd.13834 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317469010 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317469010 | ||
003 | DE-627 | ||
005 | 20231225163331.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/jocd.13834 |2 doi | |
028 | 5 | 2 | |a pubmed24n1058.xml |
035 | |a (DE-627)NLM317469010 | ||
035 | |a (NLM)33179326 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rusina, Tatiana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Erythematotelangiectatic rosacea |b The combination of 0.5% brimonidine tartrate gel and broadband pulse light therapy to reverse its effects |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.06.2021 | ||
500 | |a Date Revised 22.06.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 Wiley Periodicals LLC. | ||
520 | |a Rosacea is a common skin disease that is troublesome for both the patients and the dermatologists. Erythema, telangiectasia, papulopustular changes, and phymatous changes are the main problems faced by the patients and dermatologists in everyday practice. Due to the chronic and relapsing nature of the disease, patients are usually unsatisfied with conventional treatment methods. We report a case of a patient with rosacea, erythematotelangiectatic subtype with an eight-year history of progressive worsening and experience of combined therapy based on the broadband pulse light and topical 0.5% brimonidine tartrate gel. The effectiveness of the therapy was evaluated using multispectral skin imaging that enables to define morphological patterns of the pathological skin areas in a real-time mode as well as to create the map of hemoglobin distribution and to measure its concentration in the rosacea foci. In this case report, an efficacy and very good tolerability of the abovementioned treatment have been demonstrated | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a brimonidine | |
650 | 4 | |a broadband pulse light | |
650 | 4 | |a rosacea | |
650 | 4 | |a topical therapy | |
650 | 7 | |a Dermatologic Agents |2 NLM | |
650 | 7 | |a Brimonidine Tartrate |2 NLM | |
650 | 7 | |a 4S9CL2DY2H |2 NLM | |
700 | 1 | |a Snarskaya, Elena |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of cosmetic dermatology |d 2002 |g 20(2021), 7 vom: 10. Juli, Seite 2116-2118 |w (DE-627)NLM166816639 |x 1473-2165 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2021 |g number:7 |g day:10 |g month:07 |g pages:2116-2118 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/jocd.13834 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2021 |e 7 |b 10 |c 07 |h 2116-2118 |